|
|
.
See Category: Diseases of the eye and adnexa
See Header: Other localized visual field defect
ICD-10 (CM) Code and Descriptor
|
H53.453 |
Other localized visual field defect, bilateral
|
H53453 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 21.70%
|
27.94%
|
23.03%
|
13.84%
|
5.34%
|
2.76%
|
1.99%
|
1.11%
|
0.77%
|
0.60%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H53.453*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
227
|
229
|
|
92083
|
EXTENDED VISUAL FIELD XM |
190
|
190
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
143
|
144
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
126
|
126
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
116
|
116
|
|
97535
|
SELF CARE MNGMENT TRAINING |
115
|
313
|
|
97530
|
THERAPEUTIC ACTIVITIES |
85
|
165
|
|
82565
|
ASSAY OF CREATININE |
83
|
83
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
74
|
74
|
|
70543
|
MRI ORBT/FAC/NCK W/O &W/DYE |
73
|
73
|
|
93880
|
EXTRACRANIAL BILAT STUDY |
65
|
65
|
|
80048
|
METABOLIC PANEL TOTAL CA |
54
|
54
|
|
A9585
|
GADOBUTROL INJECTION |
51
|
3,810
|
|
G1004
|
CDSM NDSC |
40
|
48
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
40
|
40
|
|
J3010
|
FENTANYL CITRATE INJECTION |
39
|
105
|
|
15823
|
BLEPHARP UPR EYELID XCSV SKN |
39
|
39
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
38
|
3,046
|
|
84520
|
ASSAY OF UREA NITROGEN |
33
|
33
|
|
86140
|
C-REACTIVE PROTEIN |
33
|
33
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H53.453 related to the following DRG Codes:
123
|
